BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 19318480)

  • 1. Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination.
    Robinson BD; Sica GL; Liu YF; Rohan TE; Gertler FB; Condeelis JS; Jones JG
    Clin Cancer Res; 2009 Apr; 15(7):2433-41. PubMed ID: 19318480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer.
    Rohan TE; Xue X; Lin HM; D'Alfonso TM; Ginter PS; Oktay MH; Robinson BD; Ginsberg M; Gertler FB; Glass AG; Sparano JA; Condeelis JS; Jones JG
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 24895374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Microenvironment of Metastasis (TMEM) Doorways Are Restricted to the Blood Vessel Endothelium in Both Primary Breast Cancers and Their Lymph Node Metastases.
    Ginter PS; Karagiannis GS; Entenberg D; Lin Y; Condeelis J; Jones JG; Oktay MH
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31597373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis.
    Karagiannis GS; Pastoriza JM; Borriello L; Jafari R; Coste A; Condeelis JS; Oktay MH; Entenberg D
    J Vis Exp; 2019 Jun; (148):. PubMed ID: 31305525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive breast carcinoma cells from patients exhibit MenaINV- and macrophage-dependent transendothelial migration.
    Pignatelli J; Goswami S; Jones JG; Rohan TE; Pieri E; Chen X; Adler E; Cox D; Maleki S; Bresnick A; Gertler FB; Condeelis JS; Oktay MH
    Sci Signal; 2014 Nov; 7(353):ra112. PubMed ID: 25429076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.
    Axelsson K; Ljung BM; Moore DH; Thor AD; Chew KL; Edgerton SM; Smith HS; Mayall BH
    J Natl Cancer Inst; 1995 Jul; 87(13):997-1008. PubMed ID: 7543156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of secreted protein acidic in hematogenous metastasis of gastric cancer.
    Mo A; Yang SW; Jiang YX; Zhao YL; Shi Y; Qian F; Hao YX; Yu PW
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4311-4321. PubMed ID: 29077165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mena invasive (Mena(INV)) and Mena11a isoforms play distinct roles in breast cancer cell cohesion and association with TMEM.
    Roussos ET; Goswami S; Balsamo M; Wang Y; Stobezki R; Adler E; Robinson BD; Jones JG; Gertler FB; Condeelis JS; Oktay MH
    Clin Exp Metastasis; 2011 Aug; 28(6):515-27. PubMed ID: 21484349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism.
    Karagiannis GS; Pastoriza JM; Wang Y; Harney AS; Entenberg D; Pignatelli J; Sharma VP; Xue EA; Cheng E; D'Alfonso TM; Jones JG; Anampa J; Rohan TE; Sparano JA; Condeelis JS; Oktay MH
    Sci Transl Med; 2017 Jul; 9(397):. PubMed ID: 28679654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematogenous Dissemination of Breast Cancer Cells From Lymph Nodes Is Mediated by Tumor MicroEnvironment of Metastasis Doorways.
    Coste A; Karagiannis GS; Wang Y; Xue EA; Lin Y; Skobe M; Jones JG; Oktay MH; Condeelis JS; Entenberg D
    Front Oncol; 2020; 10():571100. PubMed ID: 33194666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Microvessel Density with Prognostic Factors in Invasive Ductal Carcinomas of the Breast.
    Şener E; Şipal S; Gündoğdu C
    Turk Patoloji Derg; 2016; 32(3):164-70. PubMed ID: 27562390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA.
    Harney AS; Arwert EN; Entenberg D; Wang Y; Guo P; Qian BZ; Oktay MH; Pollard JW; Jones JG; Condeelis JS
    Cancer Discov; 2015 Sep; 5(9):932-43. PubMed ID: 26269515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
    Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
    Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling events at TMEM doorways provide potential targets for inhibiting breast cancer dissemination.
    Surve CR; Duran CL; Ye X; Chen X; Lin Y; Harney AS; Wang Y; Sharma VP; Stanley ER; Cox D; McAuliffe JC; Entenberg D; Oktay MH; Condeelis JS
    bioRxiv; 2024 Mar; ():. PubMed ID: 38260319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMEM: a novel breast cancer dissemination marker for the assessment of metastatic risk.
    Oktay MH; Jones JG
    Biomark Med; 2015; 9(2):81-4. PubMed ID: 25689896
    [No Abstract]   [Full Text] [Related]  

  • 17. Microvessel quantitation in breast ductal invasive carcinoma. Correlation with proliferative activity, hormonal receptors and lymph node metastases.
    Aranda FI; Laforga JB
    Pathol Res Pract; 1996 Feb; 192(2):124-9. PubMed ID: 8692712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic features in patients with stage T1 breast carcinoma and a 0.5-cm or less lymph node metastasis. Significance of lymph node hilar tissue invasion.
    Goldstein NS; Mani A; Vicini F; Ingold J
    Am J Clin Pathol; 1999 Jan; 111(1):21-8. PubMed ID: 9894450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced PTEN expression is associated with poor outcome and angiogenesis in invasive ductal carcinoma of the breast.
    Lee JS; Kim HS; Kim YB; Lee MC; Park CS; Min KW
    Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):205-10. PubMed ID: 15551732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of MRI to estimate metastatic dissemination risk and prometastatic effects of chemotherapy.
    Karagiannis GS; Bianchi A; Sanchez LR; Ambadipudi K; Cui MH; Anampa JM; Asiry S; Wang Y; Harney AS; Pastoriza JM; Lin Y; Chen X; Jones JG; Entenberg D; Haddad D; Hodges LJ; Duong TQ; Sparano JA; Oktay MH; Branch CA; Condeelis JS
    NPJ Breast Cancer; 2022 Sep; 8(1):101. PubMed ID: 36056005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.